Electrogastrography (EGC) in Premature Infants With Feeding Intolerance
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy...
Brief Summary
Official Title: “Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide”
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
- Study Type: Interventional
- Study Design: Allocation: Non-Randomized, Primary Purpose: Treatment
Intervention(s) in this Clinical Trial
- Drug: metoclopramide
Criteria for Participation in this Clinical Trial
Inclusion:
- Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: 1 Month
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: National Center for Research Resources (NCRR) NIH
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00008736
Study ID Number: NCRR-M01RR00240-1724
ClinicalTrials.gov Identifier: NCT00008736
Health Authority: United States: Federal Government
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00008736
